EAST WINDSOR, N.J.—Sabinsa gained U.S. patent # 8,003,614 B2 for the process of manufacturing pharmaceutical and cosmeceutical applications of small peptides incorporating selenium. This patent, which is number 66 for Sabinsa, will allow for more products and applications using selenium, specifically selenodipeptides, according to the company.
L-selenocysteine, the 21st natural amino acid, is a selenium-containing amino acid that is a constituent amino acid in several important enzymes including glutathione peroxidases. The selenium-containing nutrients contribute to the biosynthesis of selenoenzymes in the body, and selenoamino acids have anti-cancer and other useful properties.
The small peptides disclosed in the patent are more water soluble and practically devoid of smell, according to Sabinsa. They are expected to have medicinal and cosmeceutical uses modulating the activities enzymes like vascular endothelial growth factor and 5-alpha reductase etc.
Sabinsa’s major selenium products include SeleniumSeLECT®, SelenoForce® and Methyselene®. Its newer selenium products include PeptiSeLect® and PeptiSelene®.
